Defunct Company
Total Trials
12
As Lead Sponsor
10
As Collaborator
2
Total Enrollment
2,206
NCT00593385
Atrium iCAST Iliac Stent Pivotal Study
Phase: N/A
Role: Lead Sponsor
Start: Oct 31, 2007
Completion: May 31, 2014
NCT00689767
COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1)
Start: Jun 30, 2008
Completion: Jul 31, 2012
NCT00804024
ClearWay™ RX Registry Trial
Start: Aug 31, 2008
Completion: Oct 31, 2010
NCT00869375
Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia
Role: Collaborator
Start: Apr 30, 2009
Completion: Jun 30, 2012
NCT00976521
The INFUSE - Anterior Myocardial Infarction (AMI) Study
Start: Sep 30, 2009
Completion: Apr 30, 2013
NCT00978952
Large Diameter Advanta™ V12 Covered Stent Trial for Coarctation of the Aorta
Completion: Apr 30, 2017
NCT01025869
The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries
Start: Dec 31, 2009
Completion: Mar 31, 2012
NCT01355939
Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh
Start: May 31, 2011
Completion: Jan 31, 2015
NCT01673373
Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension
Start: Oct 23, 2012
Completion: Oct 26, 2020
NCT04775264
Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for AF
Start: May 17, 2021
Completion: Apr 27, 2023
NCT05426759
Atrial Deganglionation as a Therapy for Cardiac Surgery Patients With Atrial Fibrillation
Start: Jun 1, 2022
Completion: Jun 30, 2023
NCT07161583
Advanta VXT and Flixene PMCF Registry
Start: Sep 30, 2025
Completion: Aug 31, 2026